The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
This work presents a new strategy to achieve highly stable electrochromic devices and bilayer film construction. A novel solution‐processable electrochromic polymer P1‐Boc with quinacridone as the conjugated backbone and t‐Boc as N‐substituted non‐conjugated solubilizing groups is designed. Thermal annealing of P1‐Boc film results in the cleavage of t‐Boc groups and the formation of N─H⋯O═C hydrogen‐bonding...
The intrinsic sluggish kinetics of the oxygen evolution reaction (OER) limit the improvement of hydrogen evolution reaction (HER) performance, and substituting the anodic oxidation of biomass materials is an alternative approach, given its lower oxidation potential and higher added value compared to those of OER. In this study, a Ni3S2‐MoS2 nanoheterojunction catalyst with strong electronic interactions...
Functional nanomaterials such as iron oxide nanoparticles have been extensively explored for the diagnosis and treatment of central nervous system diseases. However, an insufficient understanding of the comprehensive nanomaterial‐biological interactions in the brain hinders the nanomaterials from meeting the medical requirements for translational research. Here, FDA‐approved ferumoxytol, an iron oxide...
Regulation of angiogenesis is a great challenge for effective anticancer therapy. Generally, anti‐angiogenic therapies are focused on inhibition of inducers involved in pro‐angiogenic communication pathways. Despite the great potential of anti‐angiogenic therapy, engineering efficient angiogenesis inhibition agents (AIAs) is still a formidable challenge, since most anti‐angiogenic therapies are limited...